HOLOGIC INC (HOLX) Stock Fundamental Analysis
NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
HOLX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making HOLX a very profitable company, without any liquidiy or solvency issues. HOLX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes HOLX very considerable for value investing!
1. Profitability
1.1 Basic Checks
HOLX had positive earnings in the past year.
HOLX had a positive operating cash flow in the past year.
Each year in the past 5 years HOLX has been profitable.
HOLX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HOLX's Return On Assets of 6.51% is amongst the best of the industry. HOLX outperforms 87.83% of its industry peers.
HOLX's Return On Equity of 12.05% is amongst the best of the industry. HOLX outperforms 87.83% of its industry peers.
The Return On Invested Capital of HOLX (10.33%) is better than 92.06% of its industry peers.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 7.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.51% | ||
| ROE | 12.05% | ||
| ROIC | 10.33% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX's Profit Margin of 13.83% is amongst the best of the industry. HOLX outperforms 91.01% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.43%, HOLX belongs to the best of the industry, outperforming 94.71% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
Looking at the Gross Margin, with a value of 56.44%, HOLX is in line with its industry, outperforming 52.91% of the companies in the same industry.
In the last couple of years the Gross Margin of HOLX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.43% | ||
| PM (TTM) | 13.83% | ||
| GM | 56.44% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
HOLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOLX has less shares outstanding
HOLX has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.60 indicates that HOLX is not in any danger for bankruptcy at the moment.
HOLX's Altman-Z score of 3.60 is fine compared to the rest of the industry. HOLX outperforms 73.55% of its industry peers.
HOLX has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as HOLX would need 2.61 years to pay back of all of its debts.
HOLX's Debt to FCF ratio of 2.61 is amongst the best of the industry. HOLX outperforms 88.89% of its industry peers.
HOLX has a Debt/Equity ratio of 0.54. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a Debt to Equity ratio of 0.54. This is in the lower half of the industry: HOLX underperforms 63.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 2.61 | ||
| Altman-Z | 3.6 |
ROIC/WACC1.28
WACC8.1%
2.3 Liquidity
A Current Ratio of 3.24 indicates that HOLX has no problem at all paying its short term obligations.
HOLX has a Current ratio of 3.24. This is comparable to the rest of the industry: HOLX outperforms 56.61% of its industry peers.
A Quick Ratio of 2.52 indicates that HOLX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.52, HOLX is in line with its industry, outperforming 57.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.24 | ||
| Quick Ratio | 2.52 |
3. Growth
3.1 Past
HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.83%.
Measured over the past years, HOLX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
Looking at the last year, HOLX shows a small growth in Revenue. The Revenue has grown by 1.66% in the last year.
The Revenue has been growing slightly by 3.66% on average over the past years.
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
3.2 Future
HOLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.95% yearly.
HOLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.04% yearly.
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.95%
Revenue Next Year1.22%
Revenue Next 2Y2.97%
Revenue Next 3Y3.65%
Revenue Next 5Y5.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.27 indicates a correct valuation of HOLX.
Compared to the rest of the industry, the Price/Earnings ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 89.42% of the companies listed in the same industry.
HOLX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.95 indicates a reasonable valuation of HOLX.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaply inside the industry as 88.36% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of HOLX to the average of the S&P500 Index (21.94), we can say HOLX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.27 | ||
| Fwd PE | 11.95 |
4.2 Price Multiples
89.95% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
HOLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HOLX is cheaper than 91.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.68 | ||
| EV/EBITDA | 10.45 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
HOLX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.94
PEG (5Y)1.23
EPS Next 2Y6.03%
EPS Next 3Y7.34%
5. Dividend
5.1 Amount
No dividends for HOLX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
54.82
-1.65 (-2.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners105.04%
Inst Owner Change-2.35%
Ins Owners0.77%
Ins Owner Change0.36%
Market Cap12.30B
Analysts70
Price Target69.73 (27.2%)
Short Float %2.41%
Short Ratio1.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.62%
Min EPS beat(2)-0.63%
Max EPS beat(2)-0.62%
EPS beat(4)1
Avg EPS beat(4)-0.3%
Min EPS beat(4)-2.26%
Max EPS beat(4)2.31%
EPS beat(8)5
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)8.52%
EPS beat(16)13
Avg EPS beat(16)16.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.77%
Revenue beat(12)6
Avg Revenue beat(12)1.68%
Revenue beat(16)10
Avg Revenue beat(16)5.33%
PT rev (1m)-13.35%
PT rev (3m)-20.32%
EPS NQ rev (1m)-4.12%
EPS NQ rev (3m)-4.12%
EPS NY rev (1m)-1.84%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-2.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.27 | ||
| Fwd PE | 11.95 | ||
| P/S | 3.06 | ||
| P/FCF | 12.68 | ||
| P/OCF | 10.87 | ||
| P/B | 2.66 | ||
| P/tB | 38.33 | ||
| EV/EBITDA | 10.45 |
EPS(TTM)4.13
EY7.53%
EPS(NY)4.59
Fwd EY8.37%
FCF(TTM)4.32
FCFY7.89%
OCF(TTM)5.04
OCFY9.2%
SpS17.94
BVpS20.58
TBVpS1.43
PEG (NY)2.94
PEG (5Y)1.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.51% | ||
| ROE | 12.05% | ||
| ROCE | 13.02% | ||
| ROIC | 10.33% | ||
| ROICexc | 13.15% | ||
| ROICexgc | 47.7% | ||
| OM | 24.43% | ||
| PM (TTM) | 13.83% | ||
| GM | 56.44% | ||
| FCFM | 24.09% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 2.61 | ||
| Debt/EBITDA | 1.93 | ||
| Cap/Depr | 54.33% | ||
| Cap/Sales | 4.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.34% | ||
| Profit Quality | 174.26% | ||
| Current Ratio | 3.24 | ||
| Quick Ratio | 2.52 | ||
| Altman-Z | 3.6 |
F-Score8
WACC8.1%
ROIC/WACC1.28
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.95%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
Revenue Next Year1.22%
Revenue Next 2Y2.97%
Revenue Next 3Y3.65%
Revenue Next 5Y5.04%
EBIT growth 1Y11.01%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year15.4%
EBIT Next 3Y9.24%
EBIT Next 5Y6.3%
FCF growth 1Y15.42%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y17.99%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%